Watch Ticker

Imunon, Inc. Common Stock

Go to Imunon, Inc. Common Stock Website

$8.76

-0.44 (-4.78%)

Live

Previous Close

$9.2

Day Range

$8.2301 - $9.12

Previous Day Range

$8.5 - $9.42

Market Cap

$18.0 million USD

Day Vol.

133441

Previous Day Vol.

98436

Currency

USD

Primary Exchange

Nasdaq

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differenti...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Dr. Stacy Lindborg - IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call

IMUNON announced progress in its Phase 3 OVATION 3 clinical trial for IMNN-001, a DNA-mediated immunotherapy targeting advanced ovarian cancer. The company has enrolled its first patient, implemented cost conservation measures, and introduced a 15% stock dividend to shareholders.

Related tickers: IMNN.

Read Full Article

N/A - IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules

IMUNON, a clinical-stage biotechnology company, announced a $3.25 million private placement and the potential for an additional $6.5 million from the exercise of short-term warrants. The company plans to use the proceeds for working capital and general corporate purposes.

Related tickers: IMNN.

Read Full Article

Trending Tickers

Please sign in to view